Treatments

Pfizer isn’t sharing Covid vaccines with researchers for next-gen studies Researchers studying next-gen vaccines to fight an evolving Covid threat are running into problems getting existing vaccines to use in their research. Rachel Cohrs STAT

WASHINGTON — Researchers studying next-generation vaccines to fight an evolving Covid-19 threat are running into problems getting existing vaccines to use in their research.

Two antibodies identified in Israel can fight all known COVID strains, study finds Infusible to patients, antibodies are so powerful neutralizing the coronavirus they could eliminate the need for more vaccine boosters, peer-reviewed research says timesofisrael

...

The antibody reported as having been isolated at the IIBR is monoclonal, meaning it was derived from a single recovered cell and is thus potentially of more potent value in yielding a treatment.

...

EU secures more doses of Bavarian monkeypox vaccine The European Union said on Wednesday it had secured an additional 170,920 doses of the monkeypox vaccine developed by biotech firm Bavarian Nordic amid concerns about the outbreak of the disease. Reuters Reuters

...

The additional doses will be available for delivery before the end of the year, while shots that were purchased earlier are currently being distributed, the EU Commission said.

Boost high-risk people with Omicron-tailored shots first - EU officials EU officials on Tuesday recommended that the two Omicron- tailored vaccines recently endorsed by the European Medicines Agency (EMA) be first deployed in high-risk individuals. Reuters Reuters

...